Results 11 to 20 of about 40,670 (272)
VACUNA SINOPHARM… tres años después
Horizonte MédicoEl 9 de febrero de 2024 se cumplieron tres años desde que la vacuna de la empresa Sinopharm fue aplicada por primera vez en el Perú; los profesionales de la salud fueron el primer grupo poblacional en recibirla (1).
Arturo Pareja Cruz +4 more
doaj +2 more sources
Transient loss of consciousness without cerebral origin following injection of Sinopharm vaccine [PDF]
Journal of Preventive and Complementary MedicineBackground: The Sinopharm vaccine has been widely administered in Iran during COVID-19 pandemic. Clinical trials have identified several side effects associated with the Sinopharm vaccine, including pain at the injection site, fatigue, headache, and ...
Bakhtiar Ebrahimirad, Hero Payandeh
doaj +2 more sources
Sinopharm! An Unavoidable Contender in the Struggle Against COVID [Letter]
Infection and Drug Resistance, 2021 Syed Hasan Shuja,1 Dayab Asad,2 Abdul Samad Parekh3 1Dow Medical College, Karachi, Sindh, Pakistan; 2Jinnah Sindh Medical University, Karachi, Sindh, Pakistan; 3Shaheed Mohtarma Benazir Bhutto Medical College, Karachi, Sindh, PakistanCorrespondence: Syed
Shuja SH, Asad D, Parekh AS
doaj +4 more sources
Cord blood antibodies following BBIBP‐CorV (Sinopharm) vaccination during pregnancy
Immunity, Inflammation and Disease, 2023 AbstractObjectiveThis study aimed to evaluate the maternal and umbilical cord blood antibody levels, after COVID vaccination during pregnancy.MethodThe women who received the COVID‐19 vaccine (Sinopharm) during pregnancy were included. Maternal and cord blood samples were tested to detect the severe acute respiratory syndrome coronavirus 2 receptor ...
Sedigheh Hantoushzadeh +9 more
openaire +3 more sources
Guillain- Barré Syndrome (GBS) after Sinopharm vaccination
Jaffna Medical Journal, 2022 Neurological complication following Sinopharm vaccination is extremely rare and Guillain-Barre syndrome (GBS) is among the least common complication. Here we report a case of a 62-year-old male with GBS secondary to Sinopharm vaccination. A diagnosed patient with schizophrenia presented with three-day history of lower limb weakness with preceding ...
K. Nirujan +2 more
openaire +1 more source
Paracentral acute middle maculopathy and COVID‐19 vaccination: Causation versus coincidence finding
Clinical Case Reports, 2022 The current report is a rare case of paracentral acute middle maculopathy (PAMM) in a previously healthy man following COVID‐19 vaccination.
Alireza Dehghani +3 more
doaj +1 more source
Heterologous COVID-19 Vaccination; Sinopharm and Pfizer-BioNTech
Iraq Medical Journal, 2021 This short communication and highlights is the first one talking about receiving two different Anti-COVID-19 vaccines in full doses. In a small group of almost medical personals in Duhok city, Kurdistan region of Iraq, for the first time in the world 15 doctors who were vaccinated with two doses of Sinopharm at early March were revaccinated with two ...
Ameen M Mohammad, Azri S H Sgery
openaire +2 more sources
Journal of Pure and Applied Microbiology, 2023 The aim of this study was to examine the effectiveness and potential adverse reactions when providing a different Pfizer-BioNTech booster shot to 235 volunteers who had previously received the BBIBP-CorV Sinopharm primary vaccination series.
Nawfal R. Hussein +3 more
doaj +1 more source
Ischemic stroke following COVID-19 vaccination [PDF]
Journal of Research in Clinical Medicine, 2023 Following the coronavirus disease 2019 (COVID-19) vaccination, complications are expected. In this regard, coagulopathy after COVID-19 vaccination has been reported.
Nooshin Masoudian +4 more
doaj +1 more source
Follow-up of Patients With Multiple Sclerosis After COVID-19 Vaccination With Sinopharm Vaccine [PDF]
Caspian Journal of Neurological Sciences, 2023 Background: Vaccination against COVID-19 for people with multiple sclerosis (PWMS) has been recommended, but long-term follow-up needs further research.
Nazanin Razazian +5 more
doaj